The newest generation of GLP-1 drugs are being hailed by some as “miracle drugs” for the treatment of obesity. But GLP-1s are expensive, insurance coverage is limited, and not everyone with obesity can and or wants to take them. In this episode, which is based on Goldman Sachs Research’s latest Top of Mind report, obesity medicine physician Dr. Fatima Cody Stanford and Jonathan Gruber, professor of economics and chairman of the Economics Department at MIT, discuss how large the addressable market for GLP-1s actually is and the implications for US fiscal health.
If you want more insights from Goldman Sachs, make sure to visit GS.com and sign up for Briefings, a weekly newsletter from Goldman Sachs about trends spanning markets, industries, and the global economy.
The Future of Four Wheels: Episode 1, The Twin Revolution
Goldman Sachs Chairman and CEO David Solomon on the global economy, the deal-making environment, and the firm’s strategic priorities
America Powers On: Why US equities are still poised to outperform in 2024
US presidential elections outlook: Implications for policy and markets
KKR’s Henry Kravis on private equity, culture, and global markets
Uncharted territory: Navigating a ‘geopolitical recession’
Asset allocation outlook: The case for greater portfolio diversification in 2024
Focus on financials: Why banks and asset managers are constructive about the economy in 2024
Middle East risks
M&A in 2024: Navigating opportunities and challenges
Blackstone’s Kathleen McCarthy on the forces shaping the real estate industry
What China’s struggling property sector means for the global economy and markets
What’s the outlook for deal-making, corporate and investor sentiment, and markets?
Why the global economy and markets can continue to outperform in 2024
BlackRock’s Tony Kim on the ‘dawn of a new intelligence era’
The $100 billion opportunity: How anti-obesity drugs are reshaping healthcare and consumer behavior
Impactive Capital’s private equity approach to ESG-oriented activism
Is US outperformance at a turning point?
Unlocking the AI M&A Supercycle
Commercial real estate risks
Create your
podcast in
minutes
It is Free
The Commercial Edge: Unleash the Power of People
The emPOWERed Half Hour
TED Radio Hour
FT Alphachat
Freakonomics Radio
Stephanomics
Odd Lots